Fluoroquinolones efficacy in acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections
In May 2016 the U.S. Food and Drug Administration (FDA) approved changes to the labels of fluoroquinolone drugs for systemic use and advised to restrict their prescribing for the treatment of acute sinusitis, uncomplicated urinary tract infections and acute exacerbation of chronic bronchitis. This d...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
2017-02-01
|
| Series: | Клиническая микробиология и антимикробная химиотерапия |
| Subjects: | |
| Online Access: | https://cmac-journal.ru/publication/2017/1/cmac-2017-t19-n1-p025/cmac-2017-t19-n1-p025.pdf |
| _version_ | 1818029730050342912 |
|---|---|
| author | Ushkalova E.A. Zyryanov S.K. |
| author_facet | Ushkalova E.A. Zyryanov S.K. |
| author_sort | Ushkalova E.A. |
| collection | DOAJ |
| description | In May 2016 the U.S. Food and Drug Administration (FDA) approved changes to the labels of fluoroquinolone drugs for systemic use and advised to restrict their prescribing for the treatment of acute sinusitis, uncomplicated urinary tract infections and acute exacerbation of chronic bronchitis. This decision followed the recommendation of FDA Advisory Committees which concluded that the risk of rare serious and potentially permanent side effects of musculoskeletal, central and peripheral nervous system that can occur together in the same patient outweighed fluoroquinolones benefits in these infections. The article reviews data about fluoroquinolones and other antibiotics efficacy in acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections presented at FDA Advisory Committee meeting and published in available scientific literature. |
| first_indexed | 2024-12-10T05:24:19Z |
| format | Article |
| id | doaj.art-69e1d135b8a34d879cb5b6fc7fac6798 |
| institution | Directory Open Access Journal |
| issn | 1684-4386 2686-9586 |
| language | Russian |
| last_indexed | 2024-12-10T05:24:19Z |
| publishDate | 2017-02-01 |
| publisher | Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy |
| record_format | Article |
| series | Клиническая микробиология и антимикробная химиотерапия |
| spelling | doaj.art-69e1d135b8a34d879cb5b6fc7fac67982022-12-22T02:00:43ZrusInterregional Association for Clinical Microbiology and Antimicrobial ChemotherapyКлиническая микробиология и антимикробная химиотерапия1684-43862686-95862017-02-011912530cmac-2017-t19-n1-p025Fluoroquinolones efficacy in acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infectionsUshkalova E.A.0Zyryanov S.K.1RUDN University, Moscow, RussiaRUDN University, Moscow, RussiaIn May 2016 the U.S. Food and Drug Administration (FDA) approved changes to the labels of fluoroquinolone drugs for systemic use and advised to restrict their prescribing for the treatment of acute sinusitis, uncomplicated urinary tract infections and acute exacerbation of chronic bronchitis. This decision followed the recommendation of FDA Advisory Committees which concluded that the risk of rare serious and potentially permanent side effects of musculoskeletal, central and peripheral nervous system that can occur together in the same patient outweighed fluoroquinolones benefits in these infections. The article reviews data about fluoroquinolones and other antibiotics efficacy in acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections presented at FDA Advisory Committee meeting and published in available scientific literature.https://cmac-journal.ru/publication/2017/1/cmac-2017-t19-n1-p025/cmac-2017-t19-n1-p025.pdffluoroquinolonesacute sinusitisacute exacerbation of chronic bronchitisuncomplicated urinary tract infections |
| spellingShingle | Ushkalova E.A. Zyryanov S.K. Fluoroquinolones efficacy in acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections Клиническая микробиология и антимикробная химиотерапия fluoroquinolones acute sinusitis acute exacerbation of chronic bronchitis uncomplicated urinary tract infections |
| title | Fluoroquinolones efficacy in acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections |
| title_full | Fluoroquinolones efficacy in acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections |
| title_fullStr | Fluoroquinolones efficacy in acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections |
| title_full_unstemmed | Fluoroquinolones efficacy in acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections |
| title_short | Fluoroquinolones efficacy in acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections |
| title_sort | fluoroquinolones efficacy in acute sinusitis acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections |
| topic | fluoroquinolones acute sinusitis acute exacerbation of chronic bronchitis uncomplicated urinary tract infections |
| url | https://cmac-journal.ru/publication/2017/1/cmac-2017-t19-n1-p025/cmac-2017-t19-n1-p025.pdf |
| work_keys_str_mv | AT ushkalovaea fluoroquinolonesefficacyinacutesinusitisacuteexacerbationofchronicbronchitisanduncomplicatedurinarytractinfections AT zyryanovsk fluoroquinolonesefficacyinacutesinusitisacuteexacerbationofchronicbronchitisanduncomplicatedurinarytractinfections |